Nevertheless, the importance of IFN-α in psoriasis pathogenesis is unquestionable as cancer and hepatitis C patients receiving IFN-α as therapy have been seen to develop or exacerbate psoriasis upon treatment initiation [37,38]. This evidence concerns the gene IFNA1 and psoriasis.